データなし
データなし
Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell
Kronos Bio Announces Leadership Change With Deborah Knobelman Appointed as President and Interim CEO
Kronos Bio: Bischofberger Will Remain on Board and Continue to Be Available as Adviser >KRON
Press Release: Kronos Bio Announces CEO Transition and Reduction in Force
On November 22, Kronos Bio Board Approved Approximately 83% Reduction In Its Workforce; Norbert Bischofberger Resigns As President And CEO, Effective December 3, 2024 - Filing
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul